139 related articles for article (PubMed ID: 7931205)
1. Continuity of care and desipramine in primary cocaine abusers.
Hall SM; Tunis S; Triffleman E; Banys P; Clark HW; Tusel D; Stewart P; Presti D
J Nerv Ment Dis; 1994 Oct; 182(10):570-5. PubMed ID: 7931205
[TBL] [Abstract][Full Text] [Related]
2. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes.
McKay JR; Lynch KG; Shepard DS; Pettinati HM
Arch Gen Psychiatry; 2005 Feb; 62(2):199-207. PubMed ID: 15699297
[TBL] [Abstract][Full Text] [Related]
4. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.
McDowell D; Nunes EV; Seracini AM; Rothenberg J; Vosburg SK; Ma GJ; Petkova E
Drug Alcohol Depend; 2005 Nov; 80(2):209-21. PubMed ID: 15913920
[TBL] [Abstract][Full Text] [Related]
5. Do patient characteristics and initial progress in treatment moderate the effectiveness of telephone-based continuing care for substance use disorders?
McKay JR; Lynch KG; Shepard DS; Morgenstern J; Forman RF; Pettinati HM
Addiction; 2005 Feb; 100(2):216-26. PubMed ID: 15679751
[TBL] [Abstract][Full Text] [Related]
6. Desipramine facilitation of initial cocaine abstinence.
Gawin FH; Kleber HD; Byck R; Rounsaville BJ; Kosten TR; Jatlow PI; Morgan C
Arch Gen Psychiatry; 1989 Feb; 46(2):117-21. PubMed ID: 2492422
[TBL] [Abstract][Full Text] [Related]
7. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers.
Carroll KM; Rounsaville BJ; Gordon LT; Nich C; Jatlow P; Bisighini RM; Gawin FH
Arch Gen Psychiatry; 1994 Mar; 51(3):177-87. PubMed ID: 8122955
[TBL] [Abstract][Full Text] [Related]
8. Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers.
Covi L; Hess JM; Kreiter NA; Haertzen CA
Am J Drug Alcohol Abuse; 1995 Aug; 21(3):327-44. PubMed ID: 7484983
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of desipramine as an adjunct in the treatment of cocaine addiction.
Levin FR; Lehman AF
J Clin Psychopharmacol; 1991 Dec; 11(6):374-8. PubMed ID: 1837556
[TBL] [Abstract][Full Text] [Related]
10. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
[TBL] [Abstract][Full Text] [Related]
11. From the initial clinic contact to aftercare: a brief review of effective strategies for retaining cocaine abusers in treatment.
Higgins ST; Budney AJ
NIDA Res Monogr; 1997; 165():25-43. PubMed ID: 9243545
[No Abstract] [Full Text] [Related]
12. Buprenorphine effects on morphine- and cocaine-induced subjective responses by drug-dependent men.
Teoh SK; Mello NK; Mendelson JH; Kuehnle J; Gastfriend DR; Rhoades E; Sholar W
J Clin Psychopharmacol; 1994 Feb; 14(1):15-27. PubMed ID: 8151000
[TBL] [Abstract][Full Text] [Related]
13. DHEAS and POMS measures identify cocaine dependence treatment outcome.
Wilkins JN; Majewska MD; Van Gorp W; Li SH; Hinken C; Plotkin D; Setoda D
Psychoneuroendocrinology; 2005 Jan; 30(1):18-28. PubMed ID: 15358439
[TBL] [Abstract][Full Text] [Related]
14. One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects.
Carroll KM; Rounsaville BJ; Nich C; Gordon LT; Wirtz PW; Gawin F
Arch Gen Psychiatry; 1994 Dec; 51(12):989-97. PubMed ID: 7979888
[TBL] [Abstract][Full Text] [Related]
15. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
Goeb JL; Coste J; Bigot T; Ferrand I
Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
[TBL] [Abstract][Full Text] [Related]
16. Development of an outcome prediction measure for alcoholism therapy by multimodal monitoring of treatment processes.
Krampe H; Stawicki S; Ribbe K; Wagner T; Bartels C; Kroener-Herwig B; Ehrenreich H
J Psychiatr Res; 2008 Nov; 43(1):30-47. PubMed ID: 18342335
[TBL] [Abstract][Full Text] [Related]
17. Desipramine augmentation of cocaine abstinence: initial results.
Gawin FH; Byck R; Kleber HD
Clin Neuropharmacol; 1986; 9 Suppl 4():202-4. PubMed ID: 3567940
[No Abstract] [Full Text] [Related]
18. Adjunctive desipramine in the treatment of cocaine abusing schizophrenics.
Ziedonis D; Richardson T; Lee E; Petrakis I; Kosten T
Psychopharmacol Bull; 1992; 28(3):309-14. PubMed ID: 1480735
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of intensive outpatient vs. individual therapy for cocaine abusers.
Weinstein SP; Gottheil E; Sterling RC
J Addict Dis; 1997; 16(2):41-56. PubMed ID: 9083824
[TBL] [Abstract][Full Text] [Related]
20. Desipramine treatment for relapse prevention in cocaine dependence.
McElroy SL; Weiss RD; Mendelson JH; Teoh SK; McAfee B; Mello NK
NIDA Res Monogr; 1989; 95():57-63. PubMed ID: 2701323
[No Abstract] [Full Text] [Related]
[Next] [New Search]
